相似文献
1
Novel functions for NFκB: inhibition of bone formation.
Nat Rev Rheumatol. 2010 Oct;6(10):607-11. doi: 10.1038/nrrheum.2010.133. Epub 2010 Aug 10.
2
Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Bone. 2017 Apr;97:153-167. doi: 10.1016/j.bone.2017.01.022. Epub 2017 Jan 21.
3
Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
PLoS One. 2013 Dec 4;8(12):e80873. doi: 10.1371/journal.pone.0080873. eCollection 2013.
4
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
5
Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Am J Chin Med. 2017;45(8):1725-1744. doi: 10.1142/S0192415X17500938. Epub 2017 Nov 9.
6
Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Int J Mol Med. 2018 Jul;42(1):331-345. doi: 10.3892/ijmm.2018.3603. Epub 2018 Mar 30.
7
Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
Biomed Pharmacother. 2021 Jul;139:111697. doi: 10.1016/j.biopha.2021.111697. Epub 2021 May 13.
8
Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
J Ethnopharmacol. 2021 Aug 10;276:114176. doi: 10.1016/j.jep.2021.114176. Epub 2021 Apr 30.
9
Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
J Bone Miner Res. 2014 Jul;29(7):1541-53. doi: 10.1002/jbmr.2183.
10
The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
Eur J Pharmacol. 2013 Jan 5;698(1-3):57-66. doi: 10.1016/j.ejphar.2012.08.013. Epub 2012 Sep 14.
引用本文的文献
1
The dual roles of peptidoglycans: NOD1 and NOD2 inversely regulate bone metabolism.
Exp Mol Med. 2025 Aug 15. doi: 10.1038/s12276-025-01522-0.
2
Herpesvirus-Entry Mediator Inhibits the NF-B Pathway Activated by IL-17 and Fosters the Osteogenic Differentiation of Allogeneic Mesenchymal Stem Cells.
J Tissue Eng Regen Med. 2024 Aug 30;2024:8146991. doi: 10.1155/2024/8146991. eCollection 2024.
3
Atractylenolide I Attenuates Glucocorticoid-Induced Osteoporosis via Inhibiting NF-κB Signaling Pathway.
Calcif Tissue Int. 2025 Mar 12;116(1):51. doi: 10.1007/s00223-025-01358-w.
4
MicroRNA-27a transfected dental pulp stem cells undergo odonto/osteogenic differentiation via targeting DKK3 and SOSTDC1 in Wnt/BMP signaling in vitro and enhance bone formation in vivo.
J Transl Med. 2025 Feb 16;23(1):189. doi: 10.1186/s12967-025-06208-9.
5
Endothelial BMAL1 decline during aging leads to bone loss by destabilizing extracellular fibrillin-1.
J Clin Invest. 2024 Dec 16;134(24):e176660. doi: 10.1172/JCI176660.
6
Local Application of a New Chalconic Derivative (Chalcone T4) Reduces Inflammation and Oxidative Stress in a Periodontitis Model in Rats.
Antioxidants (Basel). 2024 Sep 30;13(10):1192. doi: 10.3390/antiox13101192.
7
Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials.
Menopause. 2024 Oct 1;31(10):926-939. doi: 10.1097/GME.0000000000002407. Epub 2024 Jul 30.
8
The role of autophagy/lipophagy in the response of osteoblastic cells to hyperlipidemia (Review).
Exp Ther Med. 2024 Jun 19;28(2):328. doi: 10.3892/etm.2024.12617. eCollection 2024 Aug.
9
Cedrol alleviates postmenopausal osteoporosis in rats through inhibiting the activation of the NF-κB signaling pathway.
In Vitro Cell Dev Biol Anim. 2024 Sep;60(8):903-915. doi: 10.1007/s11626-024-00921-3. Epub 2024 May 30.
10
A Multifunctional Therapeutic Strategy Using P7C3 as A Countermeasure Against Bone Loss and Fragility in An Ovariectomized Rat Model of Postmenopausal Osteoporosis.
Adv Sci (Weinh). 2024 Jun;11(21):e2308698. doi: 10.1002/advs.202308698. Epub 2024 Mar 13.
本文引用的文献
1
The mechanism of osteoclast differentiation induced by IL-1.
J Immunol. 2009 Aug 1;183(3):1862-70. doi: 10.4049/jimmunol.0803007. Epub 2009 Jul 8.
2
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
Clin Interv Aging. 2009;4:241-50. doi: 10.2147/cia.s3333. Epub 2009 Jun 9.
3
Future therapeutic targets in osteoporosis.
Curr Opin Rheumatol. 2009 Jul;21(4):380-5. doi: 10.1097/BOR.0b013e32832cbc2a.
4
Inhibition of osteoblastic bone formation by nuclear factor-kappaB.
Nat Med. 2009 Jun;15(6):682-9. doi: 10.1038/nm.1954.
5
Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1.
J Bone Miner Res. 2009 Nov;24(11):1856-68. doi: 10.1359/jbmr.090508.
6
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
J Alzheimers Dis. 2009;16(4):809-21. doi: 10.3233/JAD-2009-0976.
7
TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.
Life Sci. 2009 Apr 10;84(15-16):499-504. doi: 10.1016/j.lfs.2009.01.013. Epub 2009 Feb 3.
8
NF-kappaB functions in osteoclasts.
Biochem Biophys Res Commun. 2009 Jan 2;378(1):1-5. doi: 10.1016/j.bbrc.2008.10.146. Epub 2008 Nov 6.
9
RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice.
J Clin Invest. 2008 Jun;118(6):2088-97. doi: 10.1172/JCI33392.
10
Unraveling estrogen action in osteoporosis.
Cell Cycle. 2008 May 15;7(10):1348-52. doi: 10.4161/cc.7.10.5892. Epub 2008 Feb 29.
Zotero 插件